Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors in the central anxious program, conolidine modulates alternate molecular targets. A Science Innovations review identified that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://benefitsofconolidine89712.sharebyblog.com/37474120/the-ultimate-guide-to-alternative-natural-pain-relief-to-replace-traditional-painkillers